Updated Jul 16, 2026
Zanganeh Mahkam has filed 3 SEC Form 4 filings across 2 companies in the last 90 days — buying. Lifetime open-market purchases: $57.43M.

Mahkam Zanganeh is a corporate executive known for his roles at Pulse Biosciences, Inc. and Summit Therapeutics Inc., where he serves as Co-Chief Executive Officer and Director. He holds a significant ownership stake in these companies and has been involved in multiple SEC filings related to his positions.
| Role | Director |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-12 | SMMT | Summit Therapeutics Inc. | P — Open-market purchase | 3.81M | $13.12 | $49.99M |
| 2026-06-04 | SMMT | Summit Therapeutics Inc. | P — Open-market purchase | 100.0K | $14.60 | $1.46M |
| 2025-09-10 | SMMT | Summit Therapeutics Inc. | P — Open-market purchase | 5.0K | $18.07 | $90K |
| 2025-09-10 | SMMT | Summit Therapeutics Inc. | P — Open-market purchase | 333.4K | $17.68 | $5.89M |
| 2024-10-03 | SMMT | Summit Therapeutics Inc. | J — Other acquisition / disposition | 315.7K | $1.58 | $499K |
Mahkam Zanganeh is a corporate executive known for his roles at Pulse Biosciences, Inc. and Summit Therapeutics Inc., where he serves as Co-Chief Executive Officer and Director. He holds a significant ownership stake in these companies and has been involved in multiple SEC filings related to his positions.…
3 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 4 open-market purchases ($57.43M) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Zanganeh Mahkam profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.